Claris Lifesciences received ANDA approval for Levofloxacin Injection in US

07 Jun 2013 Evaluate

Claris Lifesciences has received an Abbreviated New Drug Application (ANDA) approval for Levofloxacin Injection; having strength of 25mg/ ml in 20 ml vials in the United States of America (US). Levofloxacin Injection is an anti-infective drug administered on adults suffering from infection such as Pneumonia, Acute Bacterial Sinusitis or Complicated Urinary Tract Infection, etc. The intravenous route of administration is considered advantageous to the patient.

Claris is also one of the few injectables companies in India to have its own front end in the US, the company markets its products through its wholly owned subsidiary Claris Lifesciences Inc. The company now has 11 ANDAs approved and has a total filing of 32 ANDAs.

Peers
Company Name CMP
Redington 268.15
Adani Enterprises 2203.00
Amrapali Industries 14.01
Rashi Peripheral 347.00
PDS 374.60
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×